MannKind to Present at Upcoming Conferences
VALENCIA, Calif., May 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation
(Nasdaq:MNKD), focused on discovering, developing and commercializing
treatments for diabetes, announced today that it will present at upcoming
*Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at
2:30 pm (ET) in New York, New York.
*Goldman Sachs 35^th Annual Global Healthcare Conference on Thursday, June
12, 2014 at 11:20 am (PT) at the Terranea Resortin Rancho Palos Verdes,
*Wells Fargo 2014 Healthcare Conference on Tuesday, June 17, 2014 at 10:00
am (ET) at the InterContinental in Boston, Massachusetts.
Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website at
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA^®, is under review by the FDA.
MannKind regularly posts copies of its press releases as well as additional
information about MannKind on its website www.mannkindcorp.com. Interested
persons can subscribe on the website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its reports with the
Securities and Exchange Commission or posts certain other information to the
CONTACT: Matthew J. Pfeffer
Chief Financial Officer
MannKind Corporation Logo
Press spacebar to pause and continue. Press esc to stop.